ghk-cu inhibits 5-alpha reductase Juvasonic® + Vitali® Copper Peptide (GHK-Cu) Bundle Ready to level up your

If it does not dissolve, or if rolling creates more cloudiness, do not use the vial

Researchers studying overlapping intracellular signalling pathways including FAK pathway activation, actin polymerisation dynamics, extracellular matrix protein expression, and cell migration behaviour frequently use both peptides within combined experimental protocols

What peptides influence metabolic health

Amylin/Calcitonin Receptor Agonism (cagrilintide) Delays gastric emptying, reduces postprandial glucagon, and strongly promotes satiety Modulates appetite-regulating centers in the hindbrain, hypothalamus, and brain reward circuits, directly influencing food intake and choice May transiently activate the renin-angiotensin-aldosterone system with dose escalation, but without blood pressure or electrolyte derangements GLP-1 Receptor Agonism (semaglutide) Stimulates glucose-dependent insulin secretion and suppresses glucagon release to improve glycemic control Reduces appetite and ad libitum energy intake, with central effects on GLP-1R-expressing nuclei in hypothalamus and brainstem Delays gastric emptying and increases satiety, contributing to progressive bodyweight loss Pharmacokinetic Profile Route of Administration Subcutaneous Dosing Frequency Once weekly Route of Administration : Subcutaneous Injection Dosing Frequency: Once weekly Half -life: Cagrilintide: 7-8 days

Appearance: White lyophilised powder

But these high doses are necessary to help treat people with a deficiency